Comparative Pharmacology
Head-to-head clinical analysis: LIPOSYN III 20 versus NUTRILIPID 20.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIPOSYN III 20 versus NUTRILIPID 20.
LIPOSYN III 20% vs NUTRILIPID 20%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Liposyn III 20% is a lipid emulsion providing essential fatty acids (linoleic and linolenic acids) and calories. It serves as a source of energy and prevents essential fatty acid deficiency by supplying triglycerides that are hydrolyzed to free fatty acids and glycerol for metabolism.
Nutrilipid 20% is an intravenous fat emulsion providing a source of calories and essential fatty acids. It is composed of soybean oil, egg yolk phospholipids, and glycerin. The triglycerides in the emulsion are hydrolyzed by lipoprotein lipase into free fatty acids and glycerol, which are then metabolized for energy production and incorporation into cell membranes.
Adults: 500 mL to 2500 mL per day via continuous intravenous infusion (including peripheral or central vein); typical rate: 0.5-1 mL/kg/h initially, increasing to 1.5-2 mL/kg/h as tolerated. Maximum infusion rate: 2.5 mL/kg/h.
Intravenous infusion of 20% lipid emulsion: 1-2 g/kg/day (5-10 mL/kg/day) as part of parenteral nutrition; maximum infusion rate: 0.11 g/kg/h (0.55 mL/kg/h).
None Documented
None Documented
The terminal elimination half-life of infused triglycerides is approximately 0.5–1 h (33–60 min). Clearance is saturable; at high infusion rates, half-life may prolong.
The terminal elimination half-life of triglycerides in NUTRILIPID 20% is approximately 30 minutes in healthy adults with normal lipid metabolism. In critically ill or lipemic patients, clearance is delayed, and half-life can exceed 6 hours, necessitating monitoring of serum triglycerides.
Primarily eliminated via endogenous lipid metabolic pathways (beta-oxidation in tissues). <5% excreted unchanged in urine; minimal biliary/fecal elimination.
NUTRILIPID 20% is a lipid emulsion; triglycerides are cleared from plasma via hydrolysis by lipoprotein lipase into free fatty acids and glycerol, which are then metabolized. Renal excretion of intact triglycerides is negligible (<1%); elimination is primarily metabolic, with less than 5% excreted unchanged in urine or feces.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion